RNA

GeneCentric CEO: It is ‘starting to become more challenging to fund a biotech company’

Posted by Jason Parker | Dec 16, 2021

WRAL TechWire discusses the future of life science, the difference between RNA and DNA, and the current and future funding environment for biotech companies with Dr. Michael Milburn, CEO of GeneCentric.

Durham life science startup Ribometrix wraps up $30M funding round

Posted by WRAL TechWire | Nov 13, 2018

Ribometrix, a three-year-old startup focused on the use of ribonucleic acid, a nucleic acid present in all cells known as RNA, to target disease, has closed on $30 million in new funding with two Triangle venture capital firms helping fuel the round.

RNA

GeneCentric CEO: It is ‘starting to become more challenging to fund a biotech company’

Durham life science startup Ribometrix wraps up $30M funding round

Categories

Tags